Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

NPSA Testing Update

6 Oct 2025 13:49

RNS Number : 2402C
Thruvision Group PLC
06 October 2025
 

Reach - non-regulatory announcement

 

6 October 2025

Thruvision Group plc

UK Government National Protective Security Authority ("NPSA") testing update

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology ("Thruvision" or the "Company" and, together with its subsidiary undertakings, the "Group"), today announces that the Thruvision LPCDD7116 has been tested following the NPSA's Discriminative Threat Detection Systems Test Method. The testing is not pass/fail but shows that the system has capability for screening non-divested individuals for mass casualty threats.

 

The NPSA has confidence that Thruvision has followed the NPSA's Discriminative Threat Detection Systems Test Method in the testing of the Thruvision LPCDD7116 and the results presented are an accurate reflection of system performance. The test method is not pass/fail and the NPSA does not endorse or approve specific products tested against it.

 

Notes for readers:

· The NPSA are the UK Government's National Technical Authority for physical and personnel security.

· As part of the Security Service, MI5, the NPSA make the UK more resilient to terrorism and state threats.

· The results are available to security professionals and buyers interested in detecting both metallic and non-metallic threats to help them understand detection performance and throughput to align with their requirements to secure their facility from current and emerging threats.

· The LPCDD7116 is the catalogue number for our standard equipment.

 

For further information please contact:

 

Thruvision Group plc

Tom Black, Executive Chairman

Victoria Balchin, Chief Executive Officer and Chief Financial Officer

+44 (0)1235 425400

Allenby Capital Limited (NOMAD & Broker)

James Reeve / Piers Shimwell (Corporate Finance)

Jos Pinnington / Amrit Nahal (Sales)

+44 (0)20 3328 5656

 

About Thruvision (www.thruvision.com)

Thruvision is a leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAAEKELKSFFA
Date   Source Headline
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSSharesave option grant to Executive Director
8th Oct 20192:00 pmRNSAward of Share Options to Executive Directors
3rd Oct 20197:00 amRNSTrading Update
23rd Sep 20191:29 pmRNSResult of Annual General Meeting
23rd Sep 20197:00 amRNSContract award announcement
16th Sep 20193:36 pmRNSThruvision trialed in London Underground station
8th Jul 20192:14 pmRNSNotice of Audited Results
24th Jun 20197:00 amRNSResults for the Year ended 31 March 2019
20th Jun 20197:00 amRNSNotice of Results
22nd May 20197:00 amRNSContract award announcement
1st May 20197:00 amRNSAppointment of Finance Director
2nd Apr 20197:00 amRNSPre-close Trading Update
7th Feb 20197:00 amRNSCapital Markets Day
18th Jan 20194:02 pmRNSAward of Share Options to Executive Directors
10th Dec 20187:00 amRNSInterim Results
3rd Dec 201812:52 pmRNSNotice of Results
2nd Nov 20181:24 pmRNSTSA Concept of Operations Development Contract
3rd Oct 20187:00 amRNSTrading Update
21st Sep 20183:57 pmRNSSharesave option grant to Executive Directors
21st Sep 201810:21 amRNSAGM Statement
7th Sep 20185:10 pmRNSHolding(s) in Company
7th Sep 20185:07 pmRNSHolding(s) in Company
24th Aug 20189:19 amRNSAmendment - Holding(s) in Company
22nd Aug 201811:30 amRNSHolding(s) in Company
21st Aug 201810:52 amRNSHolding(s) in Company
20th Aug 20183:04 pmRNSHolding(s) in Company
20th Aug 20182:53 pmRNSHolding(s) in Company
9th Aug 201812:30 pmRNSAnnouncement of Results of Tender Offer
31st Jul 20189:00 amRNSHolding(s) in Company
24th Jul 201810:21 amRNSResults of General Meeting/Tender Offer
4th Jul 20187:00 amRNSProposed Tender Offer & Notice of General Meeting
26th Jun 20187:00 amRNSAudited results for the full year 31 March 2018
21st Jun 201811:26 amRNSNotice of Audited Results
1st May 20183:53 pmRNSCapital Reduction Effective
28th Mar 20183:25 pmRNSResult of General Meeting
15th Mar 20185:13 pmRNSHolding(s) in Company
15th Mar 20182:00 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAward of Share Options to Executive Director
13th Mar 20185:29 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
13th Mar 20183:17 pmRNSHolding(s) in Company
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn
12th Mar 20182:02 pmRNSPrice Monitoring Extension
12th Mar 20187:01 amRNSShare Premium Account & Capital Redemption Reserve
12th Mar 20187:00 amRNSTrading Update & Return of Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.